Атлас SPanC-Lnc выявил почти 95 тысяч неизвестных молекул для борьбы с раком - pronedra.ru
Атлас SPanC-Lnc выявил почти 95 тысяч неизвестных молекул для борьбы с раком pronedra.ru
Атлас SPanC-Lnc выявил почти 95 тысяч неизвестных молекул для борьбы с раком pronedra.ru
“Lower-Risk” Childhood Cancer May Be More Dangerous Than It Appears SciTechDaily
Tackling the blood-brain barrier: Researchers to drive ‘paradigm shift’ in brain cancer treatment Walter and Eliza Hall Institute of Medical Research
An experimental lung cancer drug held disease in check for 89% of patients in one group. Stock Titan
Daraxonrasib demonstrates initial antitumor activity in RAS-mutant lung cancer UT MD Anderson
Residential context has a stronger association with survival for Black than White women with epithelial ovarian cancer (EOC), according to a study published online Aug. 10 in JAMA Network Open.
Рак простаты и жиры: что есть, чтобы жить дольше — новое исследование Поиск - новости науки и техники
Newly approved pancreatic cancer drug shows promise in lung cancer NBC News
Онколог назвал признаки самого летального вида рака - ТИА TverNews
Swim Across America Names its 10th Cancer Research Lab at Atrium Health Levine Cancer Institute The National Law Review
Daraxonrasib, an oral RAS inhibitor therapy, achieved durable responses in pretreated patients with RAS-mutant non-small cell lung cancer (NSCLC) in a phase 1/2 trial led by The University of Texas MD Anderson Cancer Center.
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia returned or worsened, or they died, compared…
Melbourne researchers have uncovered a critical signaling pathway that controls the timing of brain development, shedding new light on how neurodevelopmental disorders may develop. The research, led by Murdoch Children's Research Institute (MCRI) and published in Nature Communications, has revealed the genetic…
Liver cancer is difficult to treat because tumors vary greatly from patient to patient. Researchers at the University of Basel have captured this diversity by creating a collection of mini-tumors, which they use to systematically search for new treatment options. They tested more than 1,600 compounds using these…